At the same time, levels of plasma insulin and HOMA-IR in the patients with T2DM+obesity did not significantly differ from that of the patients with T2DM+obesity+CP, suggesting important contribution of obesity to IR progression in T2DM in this cohort of patients. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.